AM Pharma
Developing treatments for severe medical conditions
Utrecht, Netherlands · Founded 2001 · $239.1M raised
- Headquarters
- Utrecht
- Employees
- 11–50
- Founded
- 2001
- Business Model
- B2B
- Website
- am-pharma.com
- Total Funding
- $239.1M
- Last Round
- $52.0M Extension RoundMar 2020
- Rounds
- 6
About
AM-Pharma is a Dutch clinical-stage biopharmaceutical company developing recombinant alkaline phosphatase (recAP) therapies for inflammatory conditions including acute kidney injury (AKI) and sepsis. Founded in 2001 and headquartered in Bunnik, Netherlands, the company is advancing its lead candidate BIIB1079 through late-stage clinical trials in collaboration with Biogen.
Summary
AM Pharma is a Biotech company based in Utrecht, Netherlands, founded in 2001. It has raised $239.1M in total across 6 rounds, most recently a $52.0M Extension Round round in Mar 2020.
Tech & App Stack
5 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2020
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company